Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
Vaccinologists have not focused their research on tailoring vaccines to induce robust immune responses in the elderly.
(Shutterstock)
Immunosenescence — the decline of immune system function with age — means that vaccines are not as effective in older adults, the demographic most susceptible to many diseases, including COVID-19.
Immunity passports have been touted as a way to reopen the economy. But there are serious concerns they’ll create an incentive to intentionally contract the coronavirus.
Nearly two million antibody tests imported into Australia can’t be used to diagnose COVID-19. But it’s difficult to make an antibody test that is specific and sensitive enough.
As many as 80% of those infected with coronavirus don’t show symptoms. The reasons why are likely to come down to how your immune system responds to the virus.
A test that detects antibodies against the coronavirus behind COVID-19 would reveal those people who have already encountered the virus - and therefore who might be ok to resume normal life.
A nursing home resident who tested positive for the virus visits through the window with her daughter.
AP Photo/Ted S. Warren
Different demographics are more or less vulnerable to serious complications from the coronavirus. A virologist explains the aging-related changes in how immune systems work that are to blame.
Paxton Loke, Murdoch Children's Research Institute
If your child has accidentally eaten something you thought they were allergic to, but doesn’t have a response, they may have grown out of their food allergy. Here’s the safest way to check.